A multicenter retrospective observational study in Japan reported that a large number of lymph node metastases and advanced disease stages or certain subtypes, such as luminal-HER2, HER2, and triple negative, are risk factors for bone metastases [30]. The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.